🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 09077D209 (prev. 09077D100 )
- Market Cap
- Micro Cap
- IPO
- 10/29/2021 · $5.00/unit
Business: Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions.
Notes: July 3, 2023 -- Biofrontera Inc. (Nasdaq:BFRI) , a biopharmaceutical company specializing in the commercialization of dermatologic products, announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20 that will become effective after the close of trading at 11:59 p.m. today. Biofrontera Inc. common stock will begin trading on Nasdaq on a split-adjusted basis when the market opens on Wednesday, July 5, 2023 under the existing symbol, BFRI, and under a new CUSIP number, 09077D 209.
Company Contact
- CEO
- Erica Monaco
- CFO
- Fred Leffler
- Headquarters
- 120 Presidential Way, Suite 330, Woburn, MA 01801
- Phone
- 781-245-1325
- Investor Relations
- Anke zur Mühlen · 781-486-1539 · us-ir@biofrontera.com